Anterior Vaginal Prolapse (Cystocele)

Anterior vaginal wall prolapse (cystocele) is descent of the bladder base into the anterior vaginal wall, from weakening or a defect in the pubocervical fascia and its lateral (paravaginal) attachments to the pelvic sidewall. It is the most common site of pelvic organ prolapse (POP) and frequently coexists with apical (uterine or vaginal vault) prolapse and posterior vaginal wall prolapse (rectocele) — examine and grade all three compartments in every patient, not just the anterior wall.^[1] Symptom severity correlates only loosely with the anatomic stage of prolapse: a patient with a mild anterior bulge can be highly bothered, while a patient with an advanced prolapse may report minimal bother. Management decisions should be driven primarily by how bothersome the prolapse is to the patient, not by POP-Q stage alone.

Anterior vaginal prolapse ranges from an incidental finding on examination to a prolapse causing significant bulge, voiding, and quality-of-life symptoms. The presentation includes:

• A sensation of vaginal bulge, fullness, or pressure — "something falling out" — often the presenting complaint, and the symptom most closely correlated with genuine bother regardless of POP-Q stage.
• Symptoms characteristically worse with prolonged standing, at the end of the day, or with exertion/straining, and improved with lying down — a pattern that itself supports the diagnosis.
• Voiding dysfunction from urethral kinking or bladder-base descent: hesitancy, a sensation of incomplete emptying, a need to manually reduce the prolapse or change position to void (splinting), or positional/double voiding.
• Recurrent urinary tract infection from elevated post-void residual secondary to incomplete bladder emptying.
• Dyspareunia, or a sense of vaginal laxity noticed by the patient or partner.
• Low back or pelvic pressure/heaviness, sometimes attributed to other causes before the vaginal bulge itself is examined.
• With advanced (procident) prolapse, the exposed vaginal epithelium can become dry, thickened, or ulcerated from friction against clothing.
• Occult stress urinary incontinence: a large cystocele can kink the urethra and mask underlying stress incontinence, which may become newly apparent only once the prolapse is reduced with a pessary or repaired surgically — an important consideration for treatment planning, not just a diagnostic curiosity. See Assessment & Diagnosis.

• Vaginal childbirth — the dominant risk factor; risk increases with parity, and particularly with forceps-assisted delivery, a prolonged second stage of labour, and delivery of a larger infant.
• Obesity — chronically elevated intra-abdominal pressure accelerates connective tissue and levator ani injury over time.
• Chronic straining or elevated intra-abdominal pressure — chronic constipation and straining at stool (see Constipation in Adults), chronic cough from smoking or poorly controlled asthma/COPD (see Chronic Cough in Adults), and repetitive heavy lifting, particularly occupational.
• Aging — connective tissue laxity and levator ani weakening increase with age independent of parity.
• Menopause and the associated estrogen loss — contributes to loss of connective tissue support and can worsen symptoms even in a prolapse that was previously stable; see Special Populations.
• Prior hysterectomy — alters apical support and can predispose to subsequent anterior (and other compartment) prolapse, particularly if apical support was not adequately addressed at the time of surgery.
• Connective tissue disorders (e.g., Ehlers-Danlos syndrome) and a family history of pelvic organ prolapse, supporting an underlying connective tissue contribution independent of obstetric history.
• Prior pelvic or pelvic floor surgery.
• Chronic occupational or recreational heavy lifting.

History

• Characterize the bulge/pressure symptoms: onset, what makes them better or worse (position, time of day, activity), and the degree of bother — this drives management more than the physical stage.
• Voiding symptoms: hesitancy, incomplete emptying, a need to splint or change position to void, and any recurrent urinary tract infections.
• Defecatory symptoms: straining, incomplete emptying, or a need to splint the posterior vaginal wall or perineum to complete a bowel movement — suggests a coexisting posterior compartment (rectocele) component.
• Sexual function and any dyspareunia, and whether the patient or partner has noticed vaginal laxity.
• Full obstetric history (parity, mode of delivery, forceps use, birth weight), prior pelvic or incontinence surgery, and menopausal status.
• Modifiable contributors: chronic cough and smoking status, chronic constipation and straining pattern, and occupational or recreational heavy lifting.
• Medication review for drugs affecting bowel habit or bladder function (see Urinary Incontinence in Adults for the relevant drug-class list).

Physical examination

• Examine with the patient making a genuine Valsalva effort, supine and standing (or after ambulation) if the supine finding does not match the reported symptoms — supine-only examination without straining can significantly understage a prolapse that is more prominent on standing.
• Use a split (Sims) speculum, or the posterior blade of a bivalve speculum, to isolate and examine the anterior compartment specifically, then examine the apical and posterior compartments in turn — grade all three, since management (and surgical planning, if needed) depends on which compartments are involved, not the anterior wall alone.
• Grade using the POP-Q staging concept (Stage 0-IV) — see the table below.^[1]
• Pessary reduction stress test: with the prolapse manually reduced (for example with a pessary, a speculum blade, or a swab), ask the patient to cough or perform Valsalva and observe for urine leakage. A positive test identifies occult stress urinary incontinence that the prolapse itself was masking — document and discuss this finding before finalizing a pessary or planning surgery, since reducing or repairing the prolapse can unmask incontinence that becomes newly bothersome to the patient.
• Assess pelvic floor muscle tone and the patient's ability to voluntarily contract the pelvic floor — relevant to whether pelvic floor muscle training is likely to help.

Investigations

• Post-void residual (PVR) — can be elevated with a significant cystocele from urethral kinking or bladder-base descent; a markedly elevated PVR needs further assessment (see Red Flags & Refer).
• Urinalysis — to identify or exclude infection, particularly with recurrent UTI symptoms or an elevated PVR.
• Urodynamic testing is not routinely needed for straightforward anterior prolapse, but is reasonable, via specialist referral, when occult stress incontinence is suspected and surgical planning is underway.

Pelvic Organ Prolapse Quantification (POP-Q) staging

The POP-Q system stages the most severely prolapsed point relative to the hymen, the fixed anatomic reference point, regardless of which compartment it involves.^[1]

Formal POP-Q assessment uses 9 measured points and 3 fixed linear measurements; this simplified staging table is presented for teaching purposes and clinical communication. Detailed point-by-point measurement is a specialist (urogynecology/gynecology) skill.

• Relieve bulge, pressure, and any associated voiding or defecatory symptoms.
• Match the intensity of treatment to the degree of patient bother, not to POP-Q stage alone — a well-supported patient with minimal bother from a Stage II prolapse may need no active treatment, while a highly bothered patient with a Stage I prolapse may reasonably want intervention.
• Identify and address occult stress urinary incontinence before finalizing a treatment plan, so the patient is not surprised by newly apparent incontinence after the prolapse is reduced or repaired.
• Reduce or eliminate modifiable contributing factors (chronic cough, chronic constipation/straining, excess weight) regardless of which definitive treatment is chosen.
• Preserve or restore sexual function and quality of life.
• Prevent complications of untreated or advanced prolapse — urinary retention, recurrent urinary tract infection, and ulceration of exposed vaginal epithelium.
• Offer a genuine non-surgical option (pelvic floor muscle training, pessary) to every appropriate patient before proceeding to surgery — most patients with bothersome prolapse are reasonable candidates for a conservative trial first.

Pelvic floor muscle training (PFMT)

• Delivered by a physiotherapist specializing in pelvic floor disorders where available — individualized, supervised PFMT has better evidence for prolapse specifically than a generic self-directed program.^[2]
• A typical program involves 12-20 pelvic floor contractions, several times daily, working toward longer sustained holds, similar in principle to PFMT for stress urinary incontinence; benefit for prolapse symptoms — and, in some patients, objective prolapse stage — generally requires a genuine trial of several months (commonly cited as at least 4-6 months) before being judged.
• Most effective for mild-to-moderate (Stage I-II) prolapse; still reasonable to trial in more advanced prolapse, particularly alongside a pessary or ahead of surgery, though expectations should be set accordingly.

Modifiable contributing factors

• Weight management in patients who are overweight or obese.
• Treat chronic cough at its source — smoking cessation, and optimize control of asthma, COPD, or another chronic respiratory contributor (see Chronic Cough in Adults).
• Treat chronic constipation and straining — adequate fibre and fluid intake, and pharmacologic therapy as needed (see Constipation in Adults); counsel against habitual straining and breath-holding during defecation.
• Avoid or modify repetitive heavy lifting where feasible, particularly occupational lifting.

Pessary fitting and use

• Fitting is iterative: trial different sizes and, if needed, different types, until finding the largest comfortable pessary that stays in place through Valsalva/ambulation and does not cause pain.^[3]
• Most patients should be offered a choice between self-management (removing, cleaning, and reinserting the pessary on a regular schedule themselves) and clinic-based care (removed and reinspected by a clinician on a fixed interval) — self-management is an effective, and often preferred, option for appropriate, motivated patients, with similar efficacy to clinic-based care.
• Postmenopausal patients using a pessary should generally also use local vaginal estrogen unless contraindicated — it improves tissue tolerance and reduces the risk of erosion (see Pharmacologic Treatment Options).
• See Monitoring & Follow-Up for the ongoing surveillance a pessary requires — this is not a "fit and forget" device.

Pregnancy

Definitive (surgical) treatment is deferred until childbearing is complete, since pregnancy and delivery carry a genuine risk of recurrence after repair. A pessary can be used during pregnancy for symptom relief if the prolapse is bothersome, with the same fitting and monitoring principles as outside pregnancy; increase monitoring frequency as the pregnancy progresses given ongoing anatomic change.

Postmenopausal patients

Atrophic vaginal changes from estrogen loss commonly contribute to symptom severity and to pessary intolerance in this population. Local vaginal estrogen is a genuinely useful adjunct — see Pharmacologic Treatment Options and the Menopause chapter for complete dosing and safety guidance; it can be used even in most patients for whom systemic menopausal hormone therapy is contraindicated, since systemic absorption at recommended local doses is minimal.

Older or frail patients, and those who are not surgical candidates

A pessary is well suited as long-term, ongoing management rather than a bridge to surgery, in patients who are frail, prefer to avoid surgery, or have comorbidities that make surgery higher risk. Clinic-based (rather than self-managed) pessary care and caregiver involvement may be needed if the patient has cognitive impairment or limited dexterity.

Patients desiring future fertility

Defer definitive surgical repair, particularly any procedure involving mesh or apical suspension that could be affected by a future pregnancy and delivery; a pessary and pelvic floor muscle training are appropriate interim management.

Obesity

Weight management is a genuine, modifiable risk factor for both prolapse progression and surgical recurrence, and should be addressed as part of counselling alongside — not instead of — active prolapse management.

For a patient using a pessary, arrange scheduled follow-up regardless of whether care is self-managed or clinic-based: a clinic visit for pessary removal, vaginal examination, and reinsertion (or a size/type change if needed) is typically done at approximately 3-month intervals for most pessary types, with space-occupying types (e.g., cube) generally needing more frequent removal given their design.^[3] At each visit, examine for erosion, ulceration, unusual discharge, odour, or bleeding, and confirm the pessary is still the correct size and type as pelvic floor support, weight, or sexual activity change over time. Reinforce and reassess adherence to local vaginal estrogen co-therapy in postmenopausal patients using a pessary, since it meaningfully reduces erosion risk. For a patient on pelvic floor muscle training, reassess symptom bother and, where feasible, prolapse stage at approximately 4-6 months — continued improvement can occur with ongoing adherence beyond this point. Document baseline bother and POP-Q stage at the outset so that later reassessment is objectively comparable, and revisit the treatment plan any time symptoms meaningfully change.

1. Confirm the diagnosis and reassess staging, including all three compartments — new or worsening symptoms may reflect progression in a compartment that was not the original focus (for example, a new posterior or apical component) rather than true failure of anterior-compartment management.
2. For inadequate response to pelvic floor muscle training: confirm a genuine, adherent trial of at least 4-6 months with correct technique (consider a physiotherapy referral if not already involved) before concluding it has failed; if truly inadequate, offer a pessary trial or discuss surgical referral based on patient preference.
3. For a poorly tolerated pessary (pain, recurrent expulsion, or erosion): reassess sizing and try an alternative type; ensure local vaginal estrogen co-therapy is in place in a postmenopausal patient; if erosion or intolerance persists despite these steps, discuss surgical referral.
4. If a pessary reduction stress test was positive for occult stress urinary incontinence, ensure this is discussed with the patient and communicated at any surgical referral, since a concurrent anti-incontinence procedure may be relevant to surgical planning.
5. For bothersome symptoms that persist despite an adequate trial of both PFMT and a well-fitted pessary, or when the patient simply prefers definitive treatment: refer to gynecology/urogynecology for surgical evaluation.^[4]
6. For urinary retention, recurrent UTI from elevated post-void residual, or non-healing ulceration of exposed tissue that does not resolve with pessary adjustment or estrogen therapy: escalate rather than continuing serial conservative attempts (see Red Flags & Refer).

• Basing the treatment decision on POP-Q stage alone rather than on how bothersome the prolapse actually is to the patient.
• Examining only in the supine position without a genuine Valsalva effort (or standing, if needed) — this can significantly understage the prolapse.
• Fitting a pessary without offering, or without checking for, local vaginal estrogen co-therapy in an atrophic postmenopausal patient — increases the risk of erosion and poor tolerance.
• Treating a pessary as a "fit and forget" device — ongoing scheduled follow-up is required regardless of whether care is self-managed or clinic-based.
• Not performing a pessary reduction stress test before finalizing a treatment plan, and being surprised later by newly apparent stress urinary incontinence once the prolapse is reduced or repaired.
• Assuming surgery is the only real option for advanced (Stage III-IV) prolapse without first offering a genuine pessary trial to a patient who wants to avoid or defer surgery.
• Overlooking modifiable contributing factors — chronic cough, chronic constipation/straining, and excess weight — because a mechanical or surgical treatment is already planned.
• Missing urinary retention or a markedly elevated post-void residual in a patient reporting voiding difficulty, and not investigating further.
• Assuming any postmenopausal bleeding is simply atrophic or prolapse-related without appropriate gynecologic investigation.
• Grading or discussing only the anterior compartment when apical or posterior compartment involvement is also present — all three should be assessed and communicated.

How to use this table: Anterior vaginal prolapse itself has no pharmacologic treatment. Local vaginal estrogen is included here only as an adjunct for coexisting postmenopausal atrophic vaginal changes, and the dosing is identical to the Menopause chapter's local vaginal estrogen table — see that chapter for complete estrogen-therapy safety and counselling guidance. Select any drug name to open its complete Pharmasist Drug Database page.

Local vaginal estrogen (adjunct for postmenopausal atrophy)

Minimal systemic absorption at recommended doses — no added progestogen is needed even with an intact uterus. Genuinely useful both for symptom control when atrophic changes contribute to bulge/irritation symptoms, and to improve tissue tolerance and reduce erosion risk in a patient using a pessary.^[5]

Evidence note: Local vaginal estrogen is an adjunct for coexisting atrophic changes, not a treatment for the prolapse itself or its POP-Q stage — full estrogen-therapy dosing, safety, and counselling guidance is maintained in the Menopause chapter to keep a single source of truth for this dosing information.